Asdali, Otto H.
HRN: 23-88-55 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/11/2023
10/18/2023
IV
1.5g
Q6
CAP-MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes